NCT05596617View on ClinicalTrials.gov

Safety and Efficacy of Medications COVID-19

NACompletedINTERVENTIONAL
Enrollment

335

Participants

Timeline

Start Date

April 22, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

March 31, 2022

Conditions
Severe Covid-19
Interventions
DRUG

Oral bedtime melatonin

Different doses of oral bedtime melatonin

Trial Locations (1)

28040

Hospital Clinico San Carlos, Madrid

All Listed Sponsors
lead

Hospital San Carlos, Madrid

OTHER

NCT05596617 - Safety and Efficacy of Medications COVID-19 | Biotech Hunter | Biotech Hunter